JP2006506989A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006506989A5 JP2006506989A5 JP2004551863A JP2004551863A JP2006506989A5 JP 2006506989 A5 JP2006506989 A5 JP 2006506989A5 JP 2004551863 A JP2004551863 A JP 2004551863A JP 2004551863 A JP2004551863 A JP 2004551863A JP 2006506989 A5 JP2006506989 A5 JP 2006506989A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- seq
- immune response
- expression vector
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229920001184 polypeptide Polymers 0.000 claims 52
- 102000004196 processed proteins & peptides Human genes 0.000 claims 52
- 108090000765 processed proteins & peptides Proteins 0.000 claims 52
- 239000013604 expression vector Substances 0.000 claims 35
- 230000028993 immune response Effects 0.000 claims 32
- 241000193998 Streptococcus pneumoniae Species 0.000 claims 21
- 229940031000 streptococcus pneumoniae Drugs 0.000 claims 20
- 150000001413 amino acids Chemical class 0.000 claims 19
- 125000003275 alpha amino acid group Chemical group 0.000 claims 14
- 241000124008 Mammalia Species 0.000 claims 13
- 150000004676 glycans Chemical class 0.000 claims 13
- 229920001282 polysaccharide Polymers 0.000 claims 13
- 239000005017 polysaccharide Substances 0.000 claims 13
- 125000000539 amino acid group Chemical group 0.000 claims 12
- 101710183389 Pneumolysin Proteins 0.000 claims 10
- 230000001939 inductive effect Effects 0.000 claims 8
- 239000012634 fragment Substances 0.000 claims 6
- 241000894006 Bacteria Species 0.000 claims 5
- 230000024932 T cell mediated immunity Effects 0.000 claims 4
- 230000028996 humoral immune response Effects 0.000 claims 4
- 102000039446 nucleic acids Human genes 0.000 claims 4
- 108020004707 nucleic acids Proteins 0.000 claims 4
- 150000007523 nucleic acids Chemical class 0.000 claims 4
- 239000002773 nucleotide Substances 0.000 claims 4
- 125000003729 nucleotide group Chemical group 0.000 claims 4
- 241000894007 species Species 0.000 claims 4
- 230000000890 antigenic effect Effects 0.000 claims 3
- 230000002949 hemolytic effect Effects 0.000 claims 3
- 241000606768 Haemophilus influenzae Species 0.000 claims 2
- 241000588650 Neisseria meningitidis Species 0.000 claims 2
- 101900032831 Streptococcus pneumoniae Pneumolysin Proteins 0.000 claims 2
- 241000193990 Streptococcus sp. 'group B' Species 0.000 claims 2
- 229940045808 haemophilus influenzae type b Drugs 0.000 claims 2
- 108010052285 Membrane Proteins Proteins 0.000 claims 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 claims 1
- 102400000368 Surface protein Human genes 0.000 claims 1
- 208000015181 infectious disease Diseases 0.000 claims 1
- 230000000069 prophylactic effect Effects 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
- 239000013598 vector Substances 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US42449702P | 2002-11-07 | 2002-11-07 | |
| PCT/US2003/035529 WO2004043376A2 (en) | 2002-11-07 | 2003-11-06 | Compositions and methods for treating or preventing pneumococcal infection |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009253536A Division JP2010057501A (ja) | 2002-11-07 | 2009-11-04 | 肺炎球菌感染を治療または予防するための組成物および方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006506989A JP2006506989A (ja) | 2006-03-02 |
| JP2006506989A5 true JP2006506989A5 (enExample) | 2008-08-21 |
Family
ID=32312819
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004551863A Pending JP2006506989A (ja) | 2002-11-07 | 2003-11-06 | 肺炎球菌感染を治療または予防するための組成物および方法 |
| JP2009253536A Pending JP2010057501A (ja) | 2002-11-07 | 2009-11-04 | 肺炎球菌感染を治療または予防するための組成物および方法 |
| JP2012025451A Pending JP2012139221A (ja) | 2002-11-07 | 2012-02-08 | 肺炎球菌感染を治療または予防するための組成物および方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009253536A Pending JP2010057501A (ja) | 2002-11-07 | 2009-11-04 | 肺炎球菌感染を治療または予防するための組成物および方法 |
| JP2012025451A Pending JP2012139221A (ja) | 2002-11-07 | 2012-02-08 | 肺炎球菌感染を治療または予防するための組成物および方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US7217791B2 (enExample) |
| EP (1) | EP1558280B1 (enExample) |
| JP (3) | JP2006506989A (enExample) |
| KR (1) | KR20050086427A (enExample) |
| CN (1) | CN100443116C (enExample) |
| AU (1) | AU2003291365B2 (enExample) |
| CA (1) | CA2504938C (enExample) |
| ES (1) | ES2451620T3 (enExample) |
| TW (1) | TWI315986B (enExample) |
| WO (1) | WO2004043376A2 (enExample) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2683748C (en) | 2007-04-13 | 2016-02-16 | The Board Of Regents Of The University Of Oklahoma | Mutants of cholesterol-dependent cytolysins and uses thereof |
| GB0714963D0 (en) | 2007-08-01 | 2007-09-12 | Novartis Ag | Compositions comprising antigens |
| WO2009094730A1 (en) * | 2008-02-01 | 2009-08-06 | Newcastle Innovation Limited | Vaccine compositions |
| US20120064103A1 (en) | 2009-03-24 | 2012-03-15 | Novartis Ag | Combinations of meningococcal factor h binding protein and pneumococcal saccharide conjugates |
| WO2011030218A1 (en) | 2009-09-10 | 2011-03-17 | Novartis Ag | Combination vaccines against respiratory tract diseases |
| GB201003922D0 (en) | 2010-03-09 | 2010-04-21 | Glaxosmithkline Biolog Sa | Conjugation process |
| EP3165531B1 (en) | 2010-03-12 | 2020-11-25 | Children's Medical Center Corporation | Immunogenic composition, vaccine, and uses thereof |
| WO2012072769A1 (en) | 2010-12-01 | 2012-06-07 | Novartis Ag | Pneumococcal rrgb epitopes and clade combinations |
| US9034322B2 (en) * | 2011-04-21 | 2015-05-19 | The Rockefeller University | Streptococcus bacteriophage lysins for detection and treatment of gram positive bacteria |
| SG194733A1 (en) | 2011-05-17 | 2013-12-30 | Glaxosmithkline Biolog Sa | Vaccine against streptococcus pneumoniae |
| WO2013052643A1 (en) * | 2011-10-05 | 2013-04-11 | The Rockefeller University | Dimeric bacteriophage lysins |
| CN104519910B (zh) | 2012-03-07 | 2017-05-03 | 诺华股份有限公司 | 肺炎链球菌抗原的含佐剂制剂 |
| CA2900008C (en) | 2013-02-07 | 2025-10-07 | Children's Medical Center Corporation | PROTEIN ANTIGENS THAT CONFER PROTECTION AGAINST COLONIZATION AND/OR PNEUMOCOCCAL DISEASE |
| US12616744B2 (en) | 2014-01-21 | 2026-05-05 | Pfizer Inc. | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof |
| US9815886B2 (en) | 2014-10-28 | 2017-11-14 | Adma Biologics, Inc. | Compositions and methods for the treatment of immunodeficiency |
| ES2993430T3 (en) | 2014-11-21 | 2024-12-30 | Univ Oklahoma | Pneumolysin mutants and methods of use thereof |
| GB201610599D0 (en) * | 2016-06-17 | 2016-08-03 | Glaxosmithkline Biologicals Sa | Immunogenic Composition |
| US11951165B2 (en) | 2016-12-30 | 2024-04-09 | Vaxcyte, Inc. | Conjugated vaccine carrier proteins |
| MX2019007910A (es) | 2016-12-30 | 2019-12-05 | Sutrovax Inc | Conjugados de polipeptido-antigeno con aminoacidos no naturales. |
| US10259865B2 (en) | 2017-03-15 | 2019-04-16 | Adma Biologics, Inc. | Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection |
| BR112020004509A8 (pt) | 2017-09-07 | 2023-01-31 | Merck Sharp & Dohme | Conjugado polissacarídeo-proteína carreadora, composição imunogênica compreendendo o mesmo e uso do referido conjugado |
| IL281204B2 (en) | 2018-09-12 | 2025-07-01 | Affinivax Inc | Multivalent pneumococcal vaccines |
| AU2022342080A1 (en) | 2021-09-09 | 2024-03-28 | Affinivax, Inc. | Multivalent pneumococcal vaccines |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MC2178A1 (fr) * | 1988-12-16 | 1992-05-22 | Nederlanden Staat | Mutants de la pneumolysine et vaccins a base de pneumocoque prepares a partir de ces mutants |
| EP0687688A1 (en) * | 1993-12-17 | 1995-12-20 | Universidad De Oviedo | Antibodies against pneumolysine and their applications |
| US5565204A (en) * | 1994-08-24 | 1996-10-15 | American Cyanamid Company | Pneumococcal polysaccharide-recombinant pneumolysin conjugate vaccines for immunization against pneumococcal infections |
| AU740956B2 (en) * | 1997-07-21 | 2001-11-15 | Baxter Healthcare Sa | Modified immunogenic pneumolysin compositions as vaccines |
| GB9717953D0 (en) | 1997-08-22 | 1997-10-29 | Smithkline Beecham Biolog | Vaccine |
| EP1100921B1 (en) * | 1998-07-27 | 2007-05-02 | Sanofi Pasteur Limited | Streptococcus pneumoniae proteins and nucleic acid molecules |
| ATE318924T1 (de) * | 1998-12-04 | 2006-03-15 | Univ Manitoba | Zwei-schritte-verfahren zur impfung gegen chlamydia |
| EP1980617A1 (en) * | 1998-12-31 | 2008-10-15 | Novartis Vaccines and Diagnostics, Inc. | Improved expression of HIV polypeptides and production of virus-like particles |
| ATE319833T1 (de) * | 1999-12-17 | 2006-03-15 | Wyeth Corp | Impfstoffe zur erhöhung der immunantworten gegen herpes simplex virus |
-
2003
- 2003-11-06 CN CNB2003801027586A patent/CN100443116C/zh not_active Expired - Lifetime
- 2003-11-06 US US10/702,305 patent/US7217791B2/en not_active Expired - Lifetime
- 2003-11-06 ES ES03768757.1T patent/ES2451620T3/es not_active Expired - Lifetime
- 2003-11-06 EP EP03768757.1A patent/EP1558280B1/en not_active Expired - Lifetime
- 2003-11-06 CA CA2504938A patent/CA2504938C/en not_active Expired - Lifetime
- 2003-11-06 AU AU2003291365A patent/AU2003291365B2/en not_active Expired
- 2003-11-06 KR KR1020057008095A patent/KR20050086427A/ko not_active Ceased
- 2003-11-06 TW TW092131025A patent/TWI315986B/zh not_active IP Right Cessation
- 2003-11-06 JP JP2004551863A patent/JP2006506989A/ja active Pending
- 2003-11-06 WO PCT/US2003/035529 patent/WO2004043376A2/en not_active Ceased
-
2007
- 2007-05-14 US US11/748,270 patent/US7585669B2/en not_active Expired - Lifetime
-
2009
- 2009-11-04 JP JP2009253536A patent/JP2010057501A/ja active Pending
-
2012
- 2012-02-08 JP JP2012025451A patent/JP2012139221A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Watson et al. | Pneumococcal virulence factors and host immune responses to them | |
| CA2504938A1 (en) | Compositions and methods for treating or preventing pneumococcal infection | |
| Girard et al. | A review of vaccine research and development: meningococcal disease | |
| JP2010508276A5 (enExample) | ||
| CA2421998C (en) | Vaccine against streptococcus pneumoniae | |
| Norgren et al. | Genetic diversity in T1M1 group A streptococci in relation to clinical outcome of infection | |
| JP2006512402A5 (enExample) | ||
| JP2010535025A5 (enExample) | ||
| HRP20160685T1 (hr) | Pripravci koji sadrže pneumokokne antigene | |
| US20100166732A1 (en) | Small streptococcus pyogenes antigens and their use | |
| JP2007507487A5 (enExample) | ||
| US20120135037A1 (en) | Flagellin fusion proteins and conjugates comprising pneumococcus antigens and methods of using the same | |
| JP2004501873A5 (enExample) | ||
| JP2017523985A5 (enExample) | ||
| RU2002117308A (ru) | 85 кДа АНТИГЕН NEISSERIA | |
| JP5744842B2 (ja) | 髄膜炎菌と肺炎球菌との結合型ワクチン及びそれを使用する方法 | |
| JP2012524099A5 (enExample) | ||
| US8246964B2 (en) | Antigenic protein fragments of Streptococcus pneumoniae | |
| Haeuw et al. | The recombinant Klebsiella pneumoniae outer membrane protein OmpA has carrier properties for conjugated antigenic peptides | |
| JP2012526059A (ja) | 腸球菌由来のポリペプチド、及びワクチン接種のためのその使用 | |
| Ogunniyi et al. | Vaccine potential of pneumococcal proteins | |
| CN107847578A (zh) | 免疫原性组合物 | |
| Paton | New pneumococcal vaccines: basic science developments | |
| Fischetti et al. | Protection against streptococcal pharyngeal colonization with vaccines composed of M protein conserved regions | |
| CN110898217B (zh) | 一种肺炎链球菌疫苗及其制备方法 |